2026 Top-of-Mind Issues for Life Sciences Companies

Sheppard
Contact

In 2010, the Obama Administration largely disrupted the healthcare industry with its landmark legislation, the Affordable Care Act. We are in another such moment, where the Trump Administration is transforming the life sciences industry, not through legislation, but through regulation. Two different methods to achieve the same result: enact significant change. The way in which the Food and Drug Administration (FDA) is regulating life sciences products and enforcing the Food, Drug and Cosmetic Act is altering the foundation of the industry. We would be remiss not to recognize the significance of the moment.

Please see full publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© Sheppard

Written by:

Sheppard
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA

  • Increased readership
  • Actionable analytics
  • Ongoing writing guidance

Join more than 70,000 authors publishing their insights on JD Supra

Start Publishing »

Sheppard on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide